Drug Pipeline

Bupivacaine HCl 0.5% Injectable Solution Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
3
Active Studies
3
Recruiting
3
Top Sponsors
Active Studies by Phase
Phase 2
2
Not specified
1
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT05734625 Efficacy of Nerve Blocks for Episodic Migraine Episodic Migraine Recruiting
NCT06529432 A Study of Bupivacaine Liposome Injection in the Treatment of Pain After Thoracoscopic… Local Analgesia Via Nerve Block Recruiting
Not specified
NCT07216820 Interscalene vs Phrenic-sparing Blocks in Obesity and Effect of Maximum Inspiratory… Shoulder Surgery Recruiting
Sponsors Running Bupivacaine HCl 0.5% Injectable Solution Trials
Mayo Clinic (1) Jiangsu HengRui Medicine Co., Ltd. (1) University of North Carolina, Chapel Hill (1)
Disease Areas
Migraine (1) Obesity (1)
Get alerts when Bupivacaine HCl 0.5% Injectable Solution trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free